The following Management's Discussion and Analysis ("MD&A") is intended to help
the reader understand the financial condition of the Company as of September
30, 2022, compared with December 31, 2021, and the results of operations for the
three and nine months ended September 30, 2022, compared with corresponding
periods in 2021 of Midwest Holding Inc. and its consolidated subsidiaries. The
MD&A is provided as a supplement to, and should be read in conjunction with, our
Consolidated Financial Statements and the accompanying notes to the Consolidated
Financial Statements ("Notes") presented in "Part 1 - Item 1. Financial
Statements" of this Report and our Form 10-K for the year ended
December 31, 2021 ("2021 Form 10-K"), including the sections entitled "Part I -
Item 1A. Risk Factors," and "Part II - Item 7. Management's Discussion and
Analysis of Financial Condition and Results of Operations."

Cautionary Note Regarding Forward-Looking Statements and Risk Factors



Except for certain historical information contained herein, this report contains
certain statements that may be considered "forward-looking statements" within
the meaning of Section 21E of the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), and Section 27A of the Securities Act of 1933, as amended
(the "Securities Act"), and such statements are subject to the safe harbor
created by those sections. All statements, other than statements of historical
fact, are statements that could be deemed forward-looking statements, including
without limitation: any projections of revenues, earnings, cash flows, capital
expenditures, or other financial items; any statement of plans, strategies, and
objectives of management for future operations; any statements concerning new
products or services, or developments; any statements regarding future economic
conditions or performance; and any statements of belief and any statement of
assumptions underlying any of the foregoing. Words such as "believe," "may,"
"could," "expects," "estimates," "projects," "should," "intends," "will,"
"anticipates," and

                                       42

  Table of Contents

"likely," and variations of these words, or similar expressions, terms, or
phrases, are intended to identify such forward-looking statements.
Forward-looking statements are inherently subject to risks, assumptions, and
uncertainties, many of which cannot be predicted or quantified, which could
cause future events and actual results to differ materially from those set forth
in, contemplated by, or underlying the forward-looking statements. Factors that
could cause or contribute to such differences include, but are not limited to,
those discussed in "Item 1A. Risk Factors" of our 2021 Form 10-K and [below in
Part III - Other Information - Item 1A Risk Factors.]

Factors that may cause our actual results to differ materially from those contemplated or projected, forecast, estimated or budgeted in such forward-looking statements include among others, the following possibilities:

? our business plan, particularly including our reinsurance strategy, may not

prove to be successful;

? the success of our recent changes in executive leadership;

? our reliance on third-party insurance marketing organizations to market and


   sell our insurance products through a network of independent agents;

? adverse changes in the ratings obtained from independent rating agencies;

? failure to maintain adequate reinsurance;

? our inability to expand our insurance operations outside the 22 states and

District of Columbia in which we are currently licensed;

? our annuity products may not achieve significant market acceptance;

? we may continue to experience operating losses in the foreseeable future;

? the possible loss or retirement of one or more of our key executive personnel;

intense competition, pricing competition, the entry of new competitors, and the

? introduction of new products by new and existing competitors, many of whom have

capital and human resources in excess of ours;

adverse state and federal legislation or regulation, including limitations on

? premium levels, increases in minimum capital and reserve requirements, benefit

mandates and tax treatment of insurance products;

fluctuations in interest rates causing a reduction of investment income or

? increase in interest expense and in the market value of interest-rate sensitive

investments;

? failure to obtain new customers, retain existing customers, or reductions in

policies in force by existing customers;

higher service, administrative, or general expense due to the need for

? additional marketing, administrative or management information systems

expenditures related to implementation of our business plan;

? changes in our liquidity due to changes in asset and liability matching;

? possible claims relating to sales practices for insurance products;

? accuracy of management's assumptions and estimates;

? variability of statutory capital required to be held by insurance or

reinsurance entities; and

? lawsuits in the ordinary course of business.




                                       43

  Table of Contents

All such forward-looking statements speak only as of the date of this report.
You are cautioned not to place undue reliance on such forward-looking
statements. We expressly disclaim any obligation or undertaking to release
publicly any updates or revisions to any forward-looking statements contained
herein to reflect any change in our expectations with regard thereto or any
change in the events, conditions, or circumstances on which any such statements
are based.

Overview of Company and Business Model

Midwest Holding Inc. ("Midwest," "the Company," "we," "our," or "us") was
incorporated on October 31, 2003 for the purpose of operating a financial
services company. We are in the annuity insurance business and operate through
our wholly owned subsidiaries, American Life & Security Corp. ("American Life"),
1505 Capital LLC ("1505 Capital"), and our sponsored captive reinsurance
company, Seneca Reinsurance Company, LLC ("Seneca Re").

We are a financial services company focused on helping people plan and secure
their future by providing technology-enabled and services-oriented solutions to
support individuals' retirement through our annuity products. We distribute our
annuities through independent distributors who are primarily independent
marketing organizations ("IMOs"). Our operations are comprised of three
distinct, inter-connected businesses. We seek to reinsure substantially all of
our annuity policies with third-party reinsurers and our captive reinsurance
subsidiary, Seneca Re. Our third-party reinsurers include traditional reinsurers
and capital markets reinsurers, who are investors seeking exposure to
reinsurance revenue and typically do not have their own reinsurance platforms or
insurance-related operations. We also have the flexibility to selectively retain
assets and liabilities associated with our policies for a period of time when we
expect that doing so will provide an attractive return on our capital.

We believe that our operating capabilities and technology platform provide
annuity distributors and reinsurers with flexible and cost-effective solutions.
We seek to create value through our ability to provide the distributors and
reinsurers with annuity product innovation, speed to market for new products,
competitive rates and commissions, and streamlined customer and agent
experiences. Our capital model allows us to support increasing annuity sales
volumes with capital capacity provided by reinsurers although, in connection
with plans for future growth, we continue to monitor any need for additional
capital.

We provide an end-to-end solution to manage annuity products that includes a
broad set of product development, distribution support, policy administration,
and asset/liability management services. Our technology platform enables us to
efficiently develop, sell and administer a wide range of annuity products. Our
asset management services are also provided to third-party insurers and
reinsurers.

We currently offer annuity products, consisting of multi-year guaranteed annuity
("MYGA") and fixed indexed annuity ("FIA") policies, through IMOs that in turn
distribute our products and services to independent insurance agents in 22
states and the District of Columbia. We further provide IMOs with our product
development expertise, administrative capabilities and technology platform.

We operate our core business through three subsidiaries under one reportable
segment. American Life is a Nebraska-domiciled life insurance company that is
licensed to sell, underwrite, and market life insurance and annuity. In late
2018, American Life obtained a financial strength rating of B++ ("Good") from
A.M. Best Company ("A.M. Best"), a leading rating agency for insurance
companies, that was affirmed in December 2020 and February 2022. A.M. Best also
upgraded American Life's long-term issuer credit rating to bbb+ from bbb in
December 2020, which was  affirmed in February 2022. All of our annuities are
written by American Life.

Our other insurance subsidiary, Seneca Re, is a Vermont-domiciled sponsored
captive reinsurance company established in early 2020 to reinsure various types
of risks on behalf of American Life and third-party capital providers through
special purpose reinsurance entities known as "protected cells." Through Seneca
Re, we assist capital market investors in establishing and licensing new
protected cells. We also own 1505 Capital, which is an SEC registered investment
adviser that provides financial, investment advisory, and management services.
At September 30, 2022, 1505 Capital had approximately $494.5 million total
third-party assets under management.

We seek to deliver long-term value by growing our annuity volumes and generating
profitable fee-based revenue. We generate fees and other revenue based on the
gross deposits received on the annuity policies we issue, reinsure, and
administer.

                                       44

  Table of Contents

We seek to create value for our distribution and reinsurance partners by
facilitating product innovation, rapid speed to market for new products,
competitively priced products, streamlined customer and agent experience, and
efficient technology-enabled operations. We generate fee income from reinsurers
in the form of ceding commissions, policy administration fees, and asset
management fees. We typically receive upfront ceding commissions and expense
reimbursements at the time the policies are reinsured and policy administration
fees over the policy lifetimes. We also earn asset management fees on the assets
we hold that support the obligations of a majority of our reinsurers. In
investing on behalf of our insurance and reinsurance company subsidiaries, we
seek to maximize yield by constructing portfolios that include a diversified
portfolio of bonds, mortgages, private credit and structured securities
(including collateralized loan obligations), while minimizing the difference in
duration between our investment assets and liabilities.

By reinsuring a significant portion of the annuity policies issued, the level of
capital needed for American Life is significantly less than retaining all of the
business on its books. We believe this "capital light" approach has the
potential to produce enhanced returns for our business compared to a traditional
insurance company capital structure. This strategy helps alleviate our insurance
regulatory capital requirements because policies that are reinsured require
substantially less capital and surplus than policies retained by us.

As of September 30, 2022, approximately 45% of the deposits received in 2022 for
our annuity products were ceded to reinsurance vehicles capitalized by third
party reinsurers or held in protected cells within Seneca Re for future
reinsurance transactions.

We receive ceding commissions and expense reimbursement from reinsurers at the
time we cede our primary insurance liabilities to them, providing meaningful
cash flow. During the three months ended September 30, 2022, and 2021, we
generated $5.5 million and $4.3 million, respectively, in upfront ceding
commissions. For the nine months ended September 30, 2022 and 2021, we generated
$9.5 million and $9.3 million, respectively, in upfront ceding commissions. On
our balance sheet is an item "deferred gains on reinsurance" equaling $35.5
million and $28.6 million as of September 30, 2022, and December 31, 2021,
respectively which will be earned as revenue over the relevant reinsured annuity
contract periods. Amortization of the deferred gain on reinsurance was $1.2
million and $0.7 million for the three months ended September 30, 2022, and
2021, respectively, and was recognized as revenue under GAAP. Amortization of
the deferred gain on reinsurance was $3.3 million and $1.7 million for the nine
months ended September 30, 2022, and 2021, respectively, and was recognized as
revenue under GAAP.

For the three months ended September 30, 2022, and 2021, we generated $19.0
million and $5.8 million of revenue from investment income, realized gains on
investments, ceding commissions earned, policy administration, and asset
management fees. For the nine months ended September 30, 2022 and 2021, we
generated $21.5 million and $14.1 million of revenue from investment income,
realized gains on investments, ceding commissions earned, policy administration,
and asset management fees.

Through our ancillary services businesses we administer the policies we issue
and offer asset management services to our reinsurance partners for a fee.
Through Seneca Re, we also assist capital market investors in establishing and
licensing new special purpose reinsurance entities. We believe our broad service
offering provides a growing and valuable fee stream and expect that our policy
administration and asset management fee income will increase as we grow our
number of administered policies and the associated assets that we manage. In the
future, we expect to have opportunities to increase our policy administration
and asset management revenue by providing these services on a stand-alone basis
to new customers.

Our Products

Through American Life we presently issue several MYGA and FIA products. American
Life presently offers fixed annuity products, consisting of two MYGAs, two FIAs,
and two bonus plans associated with the FIA product. It is not presently
offering any traditional life insurance products. Fixed annuities are a type of
insurance contract in which the policyholder makes one or more premium deposits,
earning interest at a crediting rate determined in relation to a specific market
index, on a tax deferred basis. MYGAs are insurance contracts under which the
policyholder makes deposits and earns a crediting rate guaranteed for a
specified number of years before it may be changed. American Life's MYGA
products are three and five-year single premium deferred individual annuity
contracts, providing consumers with an attractive, low risk, predictable and
tax-deferred investment option. American Life's FIA products are long-term (7
and 10-year) annuity products with interest rates that are tied, in part, to
published stock market indices chosen by customers. The FIA products are
modified single premium annuity contracts

                                       45

Table of Contents



designed for individuals seeking to benefit from potential market gains with
fully protected principal. American Life began selling its MYGA and FIA products
in 2019.

In 2021, we introduced two new indexes into the selections on FIA products. The
S&P 500 ESG index for fixed annuities is comprised of a subset of S&P 500
companies built to meet the increasing needs of investors seeking socially
responsible investments aligned with a mainstream index which is published by
S&P Dow Jones Indices (S&P DJI).

Our second index introduced in 2021, the Goldman Sachs Xenith Index is a
multi-asset strategy that uses an anticipated macro regime, as identified by a
leading economic indicator, to make asset allocations. By using a leading
economic indicator, the Goldman Sachs Xenith Index differs from indices that
rely on a backward-looking methodology alone. Instead of relying purely on the
S&P 500 Index for exposure to U.S. equities, the index employs an intraday
overlay that can reduce equity exposure based on intra-day trading "signals". As
a result, the strategy incorporates real-time market movements, in addition to
other factors, in its methodology.

We expect to expand American Life's product line in the future. Depending on
market demand, we expect to consider having American Life write a variety of
insurance products, including fixed deferred, fixed indexed and other annuities.
Any new insurance products we create must be filed with and approved by
appropriate state insurance regulatory authorities before being offered to the
public. American Life's MYGA and FIA products were developed using an
independent consulting actuary, and we expect that any new products will utilize
similar services. Our long-term plan is to broaden our products to life and
Medicare supplements under attractive market conditions.

The table below sets forth American Life's MYGA and FIA deposits received during the three and nine months ended September 30, 2022 and 2021:



                                                      Three months ended September 30,                             Nine months ended September 30,
                                                             2022                        2021                            2022                        2021
                                                                                       Deposits                                                    Deposits
(In thousands)                              Deposits Received(1)                      Received(1)        Deposits Received(1)                     Received(1)
Annuity Premium
MYGA                                       $              165,123                   $        46,718     $              260,817                  $        82,279
FIA                                                        90,392                            71,208                    248,843                          285,167
Total issued                               $              255,515                   $       117,926     $              509,660                  $       367,446


1) Under generally accepted accounting principles in the United States of
America ("GAAP"), these products are defined as deposit-type contracts;
therefore, the deposits received are accounted for under GAAP as deposit-type
liabilities on our balance sheet and premiums received are not recognized as
revenue in our consolidated statement of comprehensive loss. Under Statutory
Accounting Principles ("SAP"), the MYGA and FIA premiums received are treated as
premiums written and as revenue when earned.



Industry Trends and Market Conditions

Market


We participate in a large U.S. market that we expect to grow in part due to a
number of demographic trends. As measured by annual premiums written, annuities
are the largest product line in the life, annuity, and accident and health
sector. Annuities play an important role in retirement planning by providing
individuals with stable, tax-efficient sources of income. In 2020 annuity
premium, accounted for $295 billion of annual premiums, or approximately 31% of
the $963 billion of total annual life, annuity, and accident and health premiums
according to the Insurance Information Institute. The most common annuities are
fixed and variable and can be written on an individual or group basis. Our
current products are MYGAs and FIAs written on an individual basis.

An increasing portion of the U.S. population is of retirement age and is
expected to increase the retirement income needs of retirees. The number of
people of retirement age has increased significantly since 2010, driven by the
aging of the "Baby Boomer" generation. The U.S. population over 65 years old is
forecast to grow from 56 million in 2020 to an estimated 81 million by 2040,
according to the U.S. Census Bureau, Population Estimates and Projections. This
study also forecasted that U.S. population aged over 65 years old is expected to
grow by 44% from 2020 to 2040, while the total U.S. population is expected to
grow by only 12%.  Annuities in the U.S. are distributed through a number of
channels, most of which are

                                       46

Table of Contents


independent from the insurance companies that issue annuities. Independent
distribution channels serve as the primary and a growing source of annuity
distribution. In 2020, approximately 77% of U.S. individual annuity sales
occurred through independent distributors, including independent agents,
broker-dealers, and banks, representing an increase from approximately 70% in
2016 according to U.S. Individual Annuities, 2020 Year in Review, Life Insurance
Marketing and Research Association ("LIMRA"), 2021. Independent agents are the
second largest distribution channel, behind independent broker-dealers,
accounting for approximately 19% of U.S. individual annuity sales in 2020. IMOs
provide independent agents with access to annuity products along with
operational support services and functionality to support the distribution
services of the agents. The infrastructure and support services provided by IMOs
to independent agents are critical to the success of independent agents and
their ability to serve their customers and generate additional sales.

We believe that capital markets investors have been actively seeking investing
in and acquiring insurance and reinsurance companies in recent years. Fixed
annuities provide upfront premiums and stable, long-term payment obligations and
are thus attractive sources of liability-funded assets for a variety of
traditional and alternative asset managers and investors. However, there are
significant regulatory and operational hurdles for capital providers looking to
enter the insurance market. These hurdles are exacerbated by the limited legacy
administrative capabilities, product development processes and technology
systems, of traditional insurers and reinsurers. We provide asset managers and
investors the ability to seamlessly access funding from annuities through a
variety of reinsurance entities that we can form quickly and operate efficiently
with lower upfront and ongoing regulatory and operating costs.

State expansion efforts have taken more time than anticipated, as states would
like to see a more meaningful historical financial footprint. We are working
diligently to file in more states, responding and providing increased
information to regulators and discussing how the model ensures policyholders are
protected, given the capital held and supported by the use of reinsurance.

We currently distribute annuity products through eight third-party IMOs. We
believe our product development, prompt policy processing, operating flexibility
and speed to market make us a desirable partner for insurance distributors. We
are seeking to grow by increasing volumes with our current IMOs and by
establishing new IMO relationships.

Competition



We operate in highly competitive markets with a variety of participants,
including insurance companies, financial institutions, asset managers, and
reinsurance companies. These companies compete in various forms in the annuity
market, for investment assets and for services. We seek to build strong
relationships along with offering technology-enabled and services-oriented
solutions for our partners. Our experience indicates that the market for
annuities is dynamic. The combination of the treasury market experiencing the
unprecedented rate increases and the volatility in the market resulting from the
war in Ukraine and related economic uncertainties due to inflation has opened up
investment opportunities that allow us, and our reinsurance partners, to support
more competitive rates for annuities. Based on our experience with COVID, we
expect this investment environment to be conducive to our business model. We
have been reviewing policy pricing along with reinsurer appetite to ensure we
continue to grow our business while managing risk. We have recently taken
pricing action on both our FIA and MYGA products and continue to monitor our
competitiveness in the market. We have also increased our focus on marketing,
reestablishing, and expanding our relationships on the distribution side through
various channels and are reallocating or adding resources relating to this
initiative. As a result, we experienced encouraging sales in the second and
third quarters of 2022. However, we expect competition in our market to remain
intense particularly from other well established entities providing annuity
products.

Given potential premium growth, we have capacity to cover the capital needs of
writing new business through existing reinsurers although, in connection with
plans for future growth, we continue to monitor our need (if any) for additional
capital. Additionally, we have a number of potential reinsurance transactions in
the pipeline that may close later in the year.

Interest Rate Environment



The Federal Reserve continued increasing short-term interest rates in the third
quarter of 2022, compared to the historically low levels in the same period in
2021 and the expectation communicated from U.S. federal banking officials is for
rate increases to continue during the remainder of 2022. We seek to address our
interest rate risk through managing the duration of the liabilities and
purchasing and holding quality, long-term assets mirroring that duration.

                                       47

Table of Contents

If interest rates were to rise, we believe the yield on our floating rate investments and the yield on new investment purchases would rise. We also believe our products would therefore be more attractive to consumers and our annuities sales would increase.

Discontinuation of LIBOR

The Financial Conduct Authority ("FCA"), the United Kingdom regulator of the
London Interbank Offered Rate ("LIBOR"), previously indicated that it intends to
stop compelling panel banks to submit quotes used to determine LIBOR after 2021.
On November 30, 2020, the Intercontinental Exchange ("ICE") Benchmark
Administration ("IBA"), the administrator of LIBOR, announced a consultation
regarding its intention to cease the publication of one week and two-month U.S.
Dollar LIBOR settings at the end of December 2021, but to extend the publication
of the remaining U.S. Dollar LIBOR settings (overnight and one, three, six and
12-month U.S. Dollar LIBOR) until the end of June 2023. The IBA intends to share
the results of the consultation with the FCA and publish a summary of the
responses. U.S. bank regulators acknowledged the announcement and, subject to
certain limited exceptions, advised banks to cease writing new U.S. Dollar LIBOR
contracts by the end of 2021.

We are in the process of analyzing and identifying our securities, financial
instruments and contracts that utilize LIBOR (collectively "LIBOR Instruments")
to determine if we have any material exposure to the transition from LIBOR. To
the extent we hold LIBOR Instruments, the terms of these instruments may have
fallback provisions that provide for an alternative reference rate when LIBOR
ceases to exist. For securities without adequate fallback provisions already in
place, legislation governing securities under New York law has been enacted to
provide a safe harbor for transition to the recommended alternative reference
rate. In addition, federal legislation has been introduced to provide the same
protection for securities not governed by New York law.

Notwithstanding, in preparation for the phase out of LIBOR, we may need to
renegotiate our LIBOR Instruments that utilize LIBOR. However, these efforts may
not be successful in mitigating the legal and financial risk from changing the
reference rate in our LIBOR Instruments. Furthermore, the discontinuation of
LIBOR may adversely impact our ability to manage and hedge exposures to
fluctuations in interest rates using derivative instruments.

As a result, the transition of our LIBOR Instruments to alternative reference
rates may result in adverse changes to the net investment income, fair market
value and return on those investments. We intend to continue evaluating and
monitoring the risks associated with the LIBOR transition which include
identifying and monitoring our exposure to LIBOR, monitoring the market adoption
of alternative reference rates and ensuring operational processes are updated to
accommodate alternative rates. Due to uncertainty surrounding alternative rates,
we are unable to predict the overall impact of this change at this time,
although we have experienced no adverse effect to our investment portfolio

from
this transition to date.

COVID-19

We continue to closely monitor developments related to the COVID-19 pandemic to
assess any potential adverse impact on our business. It is currently not
possible to provide a longer-term estimate of potential insurance or reinsurance
exposure or the indirect effects the pandemic may have on our results of
operations, financial condition or liquidity. We continue to monitor the Center
for Disease Control and Prevention and State of Nebraska guidelines regarding
employee safety. Our management continues to monitor our investments and cash
flows to evaluate any impact.

Critical Accounting Policies and Estimates



Part II - Item 7 - Management's Discussion and Analysis of Financial Condition
and Results of Operations included in our 2021 Form 10-K contains a detailed
discussion of our critical accounting policies and estimates. This report should
be read in conjunction with the "Critical Accounting Policies and Estimates"
discussed in our 2021 Form 10-K MD&A.

Derivatives



The Company has entered into certain derivative instruments to hedge FIA
products that guarantee the return of principal to our policyholders and credit
interest based on a percentage of the gain in a specified market index. To hedge
against adverse changes in equity indices, the Company entered into contracts to
buy equity indexed options. The change in fair value of the derivatives for
hedging the FIA index credits and the related embedded derivative liability
fluctuate from period to period based

                                       48

Table of Contents



on the change in the market interest rates. The indexed reserves are measured at
fair value for the current period and future periods. We hedge with options in
seeking to align with the terms of our FIA products, which are between seven and
ten years. We have analyzed our hedging strategy on our FIA products and, while
the correlation of the hedges to the FIA products is not matched dollar for
dollar, we believe the hedges are effective as of September 30, 2022.

American Life also has agreements with several third-party reinsurers that have
funds withheld ("FW") and modified coinsurance ("Modco") provisions under which
the assets related to the reinsured business are maintained by American Life as
collateral; however, ownership of the assets and the total return on the asset
portfolios belong to the third-party reinsurers. Under GAAP, this arrangement is
considered an embedded derivative as discussed in "Note 5 - Derivative
Instruments" to our Consolidated Financial Statements. Assets carried as
investments on American Life's financial statements for the third-party
reinsurers contained cumulative unrealized losses of approximately $14.4 million
as of September 30, 2022, and cumulative unrealized gains of $0.2 million at
December 31, 2021, respectively. The terms of the contracts with the third-party
reinsurers provide that the changes in unrealized gains and losses on the
portfolios accrue to the third-party reinsurers. To recognize changes in the
third-party unrealized gain (loss), American Life records the year-to-date
change in the Consolidated Statements of Comprehensive Loss and in amounts
recoverable from third-party reinsurers on the Consolidated Balance Sheet. As of
September 30, 2022, American Life recognized a current year gain in the embedded
derivative of $14.6 million and a gain in the embedded derivative of $0.9
million for the comparable period in 2021. If prices of investments fluctuate,
the unrealized gains or losses of the third-party reinsurers may also fluctuate;
therefore, the associated embedded derivative gain (loss) recognized by us would
be increased or decreased accordingly.

Consolidated Results of Operations - the three months ended September 30, 2022, and 2021

Comprehensive Net Income (Loss)

In this section, unless otherwise noted the discussion below first compares the three months ended September 30, 2022, to the three months ended September 30, 2021.



We incurred a comprehensive loss of $19.6 million compared to a comprehensive
loss of $2.5 million in 2021. Our revenues increased to $19.0 million from $5.8
million driven by unrealized losses from derivatives used to hedge FIA exposure
of $31.0 million due to changes in in the Federal Reserve interest rate, offset
by increases in fee revenue and investment income. Our expenses increased to
$14.3 million from $9.2 million due primarily to the interest rate increases
resulting in losses in the embedded derivative creating negative interest
credited on our FIA products and a gain from passing the losses of the
mark-to-market on the reinsurance option allowances. These decreases in expense
were offset by increases in consulting related to new software implementation.

Other reasons for the increase in comprehensive loss included:

Taxes. We expect our effective rates to decrease throughout the remainder of

1) 2022. Note 8 to our Financial Statements provides further information relating

to this tax rate increase.

Change in Realized Investment Losses (Gains). This $6.0 million change moved

2) to a gain of $4.1 million in 2022 from a loss of $2.1 million in 2021. The

increase in interest rates in 2022 decreased the value of our fixed-income

investments to a much greater extent than occurred in 2021.

Our FIA products have three components impacting our Consolidated Statements of Comprehensive Loss:

The derivatives we purchase to hedge interest rate risk we would otherwise

face from our FIA. We carry these derivatives at fair value on our

Consolidated Balance Sheets, recording the change in fair value in our

1) Consolidated Statements of Comprehensive Loss as either a realized gain or

realized loss. In 2022, the decrease in the market value of the derivative


    option assets was $23.1 million compared to an increase of $0.7 million in
    2021.

The embedded derivative in our FIAs. We carry this derivative at fair value as

of the balance sheet date, with the change in fair value recorded in the

interest credited line of our Consolidated Statements of Comprehensive Loss.

2) Interest credited for all our products was $5.7 million in 2022 compared to

$0.3 million in 2021. The decrease in the value of the embedded derivative


    related to our FIAs was included in overall interest credited. Reflecting our
    risk


                                       49

  Table of Contents

management strategy, the change in the value of the embedded derivative equaled

the change in the value of option contracts we use to hedge this exposure.

The option budget reinsurers pay us to purchase derivative assets. We mark

these assets to market at each balance sheet date. Separately, we record a

payable to the reinsurers that is owed to a reinsurer when a policy is

surrendered, an annuitant dies, or a policy lapses. We compare what the

3) reinsurer paid for the original option budget to the market value at the end

of the period. The change in the market value is added to or subtracted from

the payable to the reinsurer to cover the reinsurer's obligations to the

policyholder. This change in market value that resulted in $2.2 million and

was included in our other operating expense in 2022 compared to expense of

$0.9 million in 2021.


Revenues

The following summarizes our revenue sources for the periods indicated:



                                                Three months ended September 30,
(In thousands)                                     2022                  

2021


Investment income, net of expenses            $        12,938      $       

6,196


Net realized gains (loss) on investments                4,135              

(2,115)


Amortization of deferred gain on reinsurance            1,239              

662


Service fee revenue, net of expenses                      118              

     628
Other revenue                                             569                    400
                                              $        18,999      $           5,771


Premium revenue: Our MYGA and FIA products generated significant cash flows in
2022 and 2021; however, as indicated above, these products are defined as
investment contracts under U.S. GAAP. Accordingly, the funds we received from
our customers under these contracts were recorded on our balance sheet as a
deposit-type liability - and not as premium revenue.

Investment income, net of expenses: The components of our net investment income were as follows:



                                              Three months ended September 30,           Nine months ended September 30,
(In thousands)                                    2022                  2021                2022                  2021
Fixed maturities                            $          3,535      $          6,373    $         23,927      $         13,103
Mortgage loans                                       (2,367)                   938                 878                 1,479
Other invested assets                                  (595)                    74               4,358                   225
Other interest income                                 12,624                     -               3,403                   266
Gross investment income                               13,197                 7,385              32,566                15,073
Less: investment expenses                              (259)               (1,189)             (2,845)               (2,770)

Investment income, net of expenses $ 12,938 $

6,196 $ 29,721 $ 12,303




Investment income, net of expenses consisted, of investment income generated
from our retained investment assets that are not ceded to reinsurers. The
increase was due to the investment income earned on our bonds and mortgage loans
purchased with net proceeds from sales of our MYGA and FIA products that were
not ceded to reinsurers during the period, as well as deployment of excess cash
towards credit investments. As of September 30, 2022, and December 31, 2021, on
a gross consolidated basis, our investment portfolio (excluding cash) was $1.4
billion and $975.5 million, respectively.

Net realized losses on investments: Net realized gains on investments were $4.1
million in 2022 compared to a net realized loss of $2.1 million in 2021. The
figure included a gain of $11.5 million and $0.9 million from a total return
swap embedded derivative in 2022 and 2021, respectively. In 2022, there were net
realized losses of $7.2 million related to derivative options we own to hedge
the obligations to FIA policyholders; such losses were partially offset by an
increase in the mark-to-market change in embedded derivative liability within
interest credited expense and an increase in FIA-related mark-to-market option
allowance expense flowing through other operating expenses. The change in fair
value of FIA hedging derivatives is driven by the performance of the indices
upon which our call options are based.

                                       50

Table of Contents



American Life has treaties with several third-party reinsurers and one related
party reinsurer. In a Modco agreement, the ceding entity retains the assets
equal to the modified coinsurance reserves retained. In a FW agreement, assets
that would normally be paid over to a reinsurer are withheld by the ceding
company to permit statutory credit for unauthorized reinsurers, to reduce
potential credit risk. Under these provisions, the assets backing the treaties
are maintained by American Life as investments but the assets and total returns
or losses on the investments are owned by the reinsurers. Under GAAP, this
arrangement is considered an embedded derivative as discussed in Comprehensive
Loss to our Consolidated Financial Statements.

Assets carried as investments on American Life's financial statements for the
third-party reinsurers contained unrealized losses of approximately $14.4
million and gains of $0.2 million as of September 30, 2022, and
December 31, 2021, respectively. The terms of the contracts with the third-party
reinsurers provide that the changes in unrealized gains on the portfolios accrue
to the third-party reinsurers. Accordingly, the unrealized losses on the assets
held by American Life were offset by gains in the embedded derivative of $14.6
million and $0.2 million as of September 30, 2022, and 2021, respectively.

Amortization of deferred gain on reinsurance: The increase in 2022 to $1.2 million from $0.7 million in 2021 was due to higher deferred gain on reinsurance, driven in part by higher reinsured premiums during 2022.


Service fee revenue, net of expenses: Service fee revenue, net of expenses,
consists of fee revenue generated by 1505 Capital, for asset management services
provided to third-party clients, some of whom are our reinsurers. The decrease
in this revenue, to $0.1 million in 2022 from $0.6 million in 2021, was due
primarily to a decline in third-party assets managed by 1505 Capital.

Other revenue: Other revenue consists of revenue generated by us for providing
ancillary services such as third-party administration ("TPA") to clients and
policy surrender charges. The increase in 2022 was primarily due to increased
policy surrender charges.

Expenses

Our expenses for the periods indicated are summarized below:



                                              Three months ended September 30,
(In thousands)                                    2022                   2021
Interest credited                          $            5,682       $           284
Benefits                                                1,351                     0

Amortization of deferred acquisition costs              1,193              

    753
Salaries and benefits                                   3,751                 4,025
Other operating expenses                                2,317                 4,124
                                           $           14,294       $         9,186


Interest credited: The increase was primarily due to the interest credited in
2022 relating to the MYGA products of approximately $2.6 million and $0.8
million for 2022 and 2021, respectively, offset by interest credited related on
our retained FIA policies of approximately $3.0 million and $(0.5) million for
2022 and 2021, respectively. The FIA interest credited is related to the fair
market value of the embedded derivative, which is owed to policyholders. It
experienced a sharp decline due to the 2022 increases in the Federal Reserve
interest rates, partially offset by the realized gain on our total return swap
that is included in the net realized gain on investments above.

Amortization of deferred acquisition costs: The increase was due to the acquisition costs relating to the sale of MYGA and FIA products where we retained approximately 55% of the business in 2022 compared to the 49% retained in 2021. These figures include the deferred acquisition cost ("DAC") of the Seneca Re protected cells, SRC1 and SRC3.

Salaries and benefits: The decrease to $3.8 million compared with $4.0 million was due to slightly lower costs.

Other operating expenses: Other operating expenses were approximately $1.8 million lower due primarily to:

Our FIA products have embedded derivatives included in the account value that

are market driven. The FIA reinsurers pay an option allowance to American Life

? to purchase derivatives. As of September 30, 2022, and 2021, the mark-to-market

on those allowances were in a negative position so American Life incurred $2.2


   million and $4.3 million,


                                       51

  Table of Contents

respectively, of income and receivable from the reinsurers for that market value

true-up. As the market fluctuates going forward, the mark-up of the option

allowance will go up or down.

Offset due to increases in other operating expenses of approximately $1.1

? million was due to building foundational capabilities to support growth along

with costs that are variable with increased premiums written related to

technology support, distribution, product design and premium taxes.

Taxes


Income tax expense increased by $1.6 million to an expense of $1.2 million in
2022 from a benefit of $0.4 million in 2021. This change was primarily driven by
the change in the reinsurance modified coinsurance tax reserves discussed.

Consolidated Results of Operations - Nine months Ended September 30, 2022, and 2021

Comprehensive Net Income (Loss)

In this section, unless otherwise noted the discussion below first compares the nine months ended September 30, 2022, to the nine months ended September 30, 2021.



We incurred a comprehensive loss of $38.7 million in 2022 compared to a
comprehensive loss of $8.8 million in 2021. Our revenues increased to $21.5
million from $14.1 million reflecting an overall increase in investment income
and fee revenue; offset by realized losses due to the increases in the Federal
Reserve interest rate. Our expenses decreased to $9.6 million from $21.9
million, primarily due to the Federal Reserve interest rate increases resulting
in losses in the embedded derivative creating negative interest credited on our
FIA product and a gain from passing the losses of the mark-to-market on the
reinsurance option allowances. These decreases in expense were offset by
increases in consulting fees.

Other reasons for the increase in Consolidated Statements of Comprehensive Loss:

Taxes. We expect the effective rates will decrease throughout the remainder of

1) 2022. Note 8 to our Financial Statements provides further information related

to this increase in tax rate.

Change in Realized Investment Losses (Gains). This change was a loss of $14.7

2) million in 2022 compared with a loss of $2.7 million in 2021. The increase in

interest rates in 2022 decreased the value of our fixed-income investments to

a much greater extent than occurred in 2021.

Our FIA products have three components influencing our Consolidated Statements of Comprehensive Loss:

The derivatives we purchase to hedge interest rate risk we would otherwise

face from our FIA. We carry these derivatives at fair value on our

Consolidated Balance Sheets, recording the change in fair value in our

1) Consolidated Statements of Comprehensive Loss as either a realized gain or

realized loss. In 2022, the decrease in the market value of the derivative

option assets was $31.0 million compared to the decrease in market value of

the derivative option assets of $4.5 million in 2021 in our net realized gain

on investments.

The embedded derivative in our FIAs. We carry this derivative at fair value as

of the balance sheet date, with the change in fair value recorded in the

interest credited line of our Consolidated Statements of Comprehensive Loss.

Interest credited for all of our products was a negative $6.5 million in 2022

2) compared with $1.9 million in 2021. The decrease in the value of the embedded

derivative related to our FIAs was included to the overall interest credited.

Reflecting our risk management strategy, the change in the value of the

embedded derivative equaled the change in the value of option contracts we use

to hedge this exposure.

The option budget reinsurers pay us to purchase derivative assets. We mark

these assets to market at each balance sheet date. Separately, we record a

payable to the reinsurers that is owed to a reinsurer when a policy is

3) surrendered, an annuitant dies, or a policy lapses. We compare what the

reinsurer paid for the original option budget to the market value at the end

of the period. The change in the market value is added to or subtracted from


    the payable to the reinsurer


                                       52

  Table of Contents

to cover the reinsurer's obligations to the policyholder. This change in market

value that resulted in negative $2.2 million was included in our other operating

expense in 2022 compared to a negative $4.3 million expense in 2021.

Revenues

The following summarizes our revenue sources for the periods indicated:



                                                 Nine months ended September 30,
(In thousands)                                      2022                  

2021


Investment income, net of expenses            $          29,721      $     

12,303


Net realized losses on investments                     (14,676)            

(2,704)


Amortization of deferred gain on reinsurance              3,251            

1,711


Service fee revenue, net of expenses                      1,632            

   1,738
Other revenue                                             1,530                1,007
                                              $          21,458      $        14,055
Premium revenue: Our MYGA and FIA products generated significant cash flows in
2022 and 2021; however, as indicated above, these products are defined as
investment contracts under U.S. GAAP. Accordingly, the funds we received from
our customers under these contracts were recorded on our balance sheet as a
deposit-type liability - and not as premium revenue.

Investment income, net of expenses: Our net investment income components are as
follows:

                                       Nine months ended September 30,
(In thousands)                            2022                  2021
Fixed maturities                    $         10,079      $         13,103
Mortgage loans                                   878                 1,479
Other invested assets                          4,358                   225
Other interest income                         17,251                   266
Gross investment income                       32,566                15,073
Less: investment expenses                    (2,845)               (2,770)

Investment income, net of expenses  $         29,721      $         12,303


Investment income, net of expenses consisted of investment income generated from
our retained investment assets that are not ceded to reinsurers. The increase
was due to the investment income earned on our bonds and mortgage loans
purchased with the sales of our MYGA and FIA products that were not ceded to
reinsurers during the period, as well as deployment of excess cash towards
credit investments. As of September 30, 2022, and December 31, 2021, on a gross
consolidated basis, our investment portfolio (excluding cash) was $1.4 billion
and $975.5 million, respectively.

Net realized losses on investments: Net realized losses on investments were
$14.7 million in 2022 compared to a loss of $2.7 million in 2021. The figure
included a gain of $14.6 million and $0.9 million from a total return swap
embedded derivative in 2022 and 2021, respectively. In 2022, there were net
realized losses of $35.9 million related to derivative options we own to hedge
the obligations to FIA policyholders; such losses were partially offset by an
increase in the mark-to-market change in embedded derivative liability within
interest credited expense and an increase in FIA-related mark-to-market option
allowance expense flowing through other operating expenses. The change in fair
value of FIA hedging derivatives is driven by the performance of the indices
upon which our call options are based.

American Life has treaties with several third-party reinsurers and one related
party reinsurer. In a Modco agreement, the ceding entity retains the assets
equal to the modified coinsurance reserves retained. In a FW agreement, assets
that would normally be paid over to a reinsurer are withheld by the ceding
company to permit statutory credit for unauthorized reinsurers, to reduce
potential credit risk. Under these provisions with third-party reinsurers, the
assets backing the treaties are maintained by American Life as investments but
the assets and total returns or losses on the investments are owned by the
reinsurers. Under GAAP, this arrangement is considered an embedded derivative as
discussed in Comprehensive Loss to our Consolidated Financial Statements.

                                       53

Table of Contents



Assets carried as investments on American Life's financial statements for the
third-party reinsurers contained unrealized losses of approximately $14.4
million as of September 30, 2022, and unrealized gains of $0.2 million as of
December 31, 2021, respectively. The terms of the contracts with the third-party
reinsurers provide that the changes in unrealized gains on the portfolios accrue
to the third-party reinsurers. Accordingly, the change in unrealized gains and
losses on the assets held by American Life were offset by gains in the embedded
derivative of $14.6 million and a loss in the embedded derivative of $0.9
million as of September 30, 2022, and 2021, respectively. We account for this
unrealized gain (loss) pass-through by recording an equivalent realized gain or
(loss) on our Consolidated Statements of Comprehensive Loss and in amounts
payable to our third-party reinsurers on the Consolidated Balance Sheets.

Amortization of deferred gain on reinsurance: The increase in 2022 to $3.3 million from $1.7 million in 2021 was due to higher deferred gain on reinsurance, driven in part by higher reinsured premiums during 2022.


Service fee revenue, net of expenses: Service fee revenue, net of expenses,
consists of fee revenue generated by 1505 Capital, for asset management services
provided to third-party clients, some of whom are our reinsurers. The decrease
in this revenue, to $1.6 million in 2022 from $1.71 million in 2021, was due
primarily to the assets managed by 1505 Capital.

Other revenue: Other revenue consists of revenue generated by providing
ancillary services such as third-party administration ("TPA") to clients and
policy surrender charges. The increase in 2022 was primarily due to increased
policy surrender charges.

Expenses

Our expenses for the periods indicated are summarized below:



                                              Nine months ended September 30,
(In thousands)                                   2022                  2021
Interest credited                          $         (6,489)      $         1,868

Amortization of deferred acquisition costs             3,095               

1,780
Salaries and benefits                                 12,366               11,466
Other operating expenses                             (1,744)                6,769
                                           $           9,573      $        21,883
Interest credited: The decrease was primarily due to the interest credited in
2022 relating to the MYGA products of approximately negative $4.6 million and
$1.8 million for 2022 and 2021, respectively, offset by interest credited
related on our retained FIA policies of approximately negative $11.1 million and
$0.1 million for 2022 and 2021, respectively. The FIA interest credited is
related to the fair market value of the embedded derivative which is owed to
policyholders which experienced a sharp decline due to the increases in the
Federal Reserve interest rates, partially offset by the realized gain on our
total return swap that is included in the net realized gain on investments
above.

Amortization of deferred acquisition costs: The increase was due to the
acquisition costs relating to the sale of American Life's MYGA and FIA products
where we retained approximately 58% of the business in 2022 compared to the 47%
retained in 2021. These figures include the DAC of Seneca Re protected cells,
SRC1 and SRC3.

Salaries and benefits: The increase to $12.4 million compared with $11.5 million
was due to costs incurred to attract and add personnel to service our business
growth and the cost related to non-cash stock consideration. We have hired more
in-house expertise to service our growth initiatives and reduce the reliance on
third-party providers.

Other operating expenses: Other operating expenses were approximately $8.5 million lower due primarily to:

Our FIA products have embedded derivatives included in the account value that

are market driven. The FIA reinsurers pay an option allowance to American Life

to purchase derivatives. As of September 30, 2022 and 2021, the mark-to-market

? on those allowances were in a negative position so American Life incurred $13.9

million and $1.9 million, respectively, of income and receivable from the


   reinsurers for that market value true-up. As the market fluctuates going
   forward, the mark-up of the option allowance will go up or down.


                                       54

  Table of Contents

Offset due to increases in other operating expenses of approximately $2.5

? million was due to fees to consultants to assist in implementing our business

plan and new accounting software, increased audit and actuarial costs, and


   overhead office expenses to support our plan growth of our business.

Taxes

Income tax expense increased by $2.0 million to $3.8 million in 2022 from $1.8 million in 2021. This change was primarily driven by the change in the reinsurance modified coinsurance tax reserves discussed above.

Investments



Most investments on our Consolidated Balance Sheets are held on behalf of our
reinsurers as collateral under our reinsurance agreements. As a result, our
investment allocations are largely a function of our collective reinsurer
investment allocations. While the reinsurers have the investment risk on these
assets, we typically restrict their investment allocations via control over the
selection of the asset managers as well as asset restrictions set forth in
investment guidelines and control over the investment managers. In many of our
reinsurance agreements, 1505 Capital acts as the asset manager for the invested
assets for a fee.

Our investment guidelines relate primarily to collateralized loan obligations,
corporate bonds, commercial mortgages on real estate, mortgage-backed
securities, and term loans. The duration of our investments is 5 to 10 years in
line with that of our liabilities. We do allow non-U.S. dollar denominated
investments where the foreign exchange risk is hedged back to U.S. dollars.

The following table shows the carrying value of our investments by investment
category and cash and cash equivalents, and the percentage of each to total
invested assets as of September 30, 2022, and December 31, 2021. Increases in
fixed maturity securities primarily resulted from the proceeds of our new MYGA
and FIA products during 2022. Most of the investments as of September 30, 2022,
and December 31, 2021 are held as collateral for our reinsurers.

                                           September 30, 2022          December 31, 2021
                                          Carrying      Percent      Carrying      Percent
(In thousands)                              Value       of Total       Value       of Total
Fixed maturity securities:
Bonds:
U.S. government obligations              $     1,495         0.1 %  $     1,882         0.2 %
Mortgage-backed securities                   211,343        13.3         55,280         4.9
Asset-backed securities                       34,648         2.2         24,951         2.2
Collateralized loan obligations              275,375        17.3        274,523        24.6
States and political
subdivisions-general obligations                 102           -           

114           -
States and political
subdivisions-special revenue                     121           -          5,612         0.5
Corporate                                     37,924         2.4         37,139         3.3
Term loans                                   476,522        30.0        267,468        23.9
Trust preferred                                    0           -          2,237         0.2
Redeemable preferred stock                    10,551         0.7         14,090         1.3
Total fixed maturity securities            1,048,081        66.0        683,296        61.1
Mortgage loans on real estate, held
for investment                               204,423        12.9        183,203        16.4
Derivatives                                   11,840         0.7         23,022         2.1
Equity securities                              9,325         0.6         21,869         2.0
Other invested assets                         78,569         4.9         35,293         3.2
Investment escrow                                344           -          3,611         0.3

Federal Home Loan Bank (FHLB) stock              501           -           

500           -
Preferred stock                               21,579         1.5         18,686         1.7
Notes receivable                               6,189         0.4          5,960         0.5
Policy Loans                                      21           -             87           -
Cash and cash equivalents                    208,664        13.0        142,013        12.7
Total investments, including cash and
cash equivalents                         $ 1,589,536       100.0 %  $ 1,117,540       100.0 %


                                       55

  Table of Contents

The following table shows the distribution of the credit ratings of our portfolio of fixed maturity securities by carrying value as of September 30, 2022, and December 31, 2021.



                             September 30, 2022       December 31, 2021
                            Carrying                 Carrying
(In thousands)                Value       Percent      Value      Percent
AAA and U.S. Government    $    66,886        6.4 %  $   2,674        0.4 %
AA                                 437          -          482        0.1
A                              339,322       32.4      168,141       24.6
BBB                            568,588       54.2      462,699       67.7
Total investment grade         975,233       93.0      633,996       92.8
BB and below                    72,848        7.0       49,300        7.2
Total                      $ 1,048,081      100.0 %  $ 683,296      100.0 %

Approximately 93% and 92.8% of all fixed maturity securities were investment grade as of September 30, 2022, and December 31, 2021, respectively.

We expect that the net proceeds from our MYGA and FIA products sales will continue to result in an increase in investable assets in future periods.

Market Risks of Financial Instruments



The primary market risks affecting the investment portfolio are interest rate
risk, credit risk and liquidity risk. With respect to investments that we hold
on our Consolidated Balance Sheets as collateral, our reinsurers bear the market
risks related to these investments, and we bear the market risks on any net
retained investments.

Interest Rate Risk



Interest rate risk arises from the price sensitivity of investments to changes
in interest rates. Interest and dividend income represent the greatest portion
of an investment's return for most fixed maturity securities in stable interest
rate environments. The changes in the fair value of such investments are
inversely related to changes in market interest rates. As interest rates fall,
the interest and dividend streams of existing fixed-rate investments become more
valuable and fair values rise. As interest rates rise, the opposite effect
occurs. Our liabilities also have interest rate risk although GAAP does not
require our liabilities to be marked to market. We mitigate interest rate risk
by monitoring and matching the duration of assets compared to the duration

of
liabilities.

Credit Risk

We are exposed to credit risk through counterparties and within the investment
portfolio. Credit risk relates to the uncertainty associated with an obligor's
ability to make timely payments of principal and interest in accordance with the
contractual terms of an instrument or contract. We manage our credit risk
through diversification of investments among many corporations and numerous
industries. Additionally, our investment policy limits the size of holding

in
any particular issuer.

Liquidity Risk

We are exposed to liquidity risk when liabilities come due. In order to pay a
policyholder, we may need to liquidate assets. If our assets are illiquid
assets, we might be unable to convert an asset into cash without giving up
capital and income due to a lack of buyers or an inefficient market. We seek to
mitigate this risk by keeping a portion of our investment portfolio in liquid
investments.

Statutory Accounting and Regulations



Our primary insurance subsidiary, American Life, is required to prepare
statutory financial statements in accordance with SAP prescribed by the NDOI.
SAP primarily differs from GAAP by charging policy acquisition costs to expense
as incurred, establishing future benefit liabilities using actuarial assumptions
as well as valuing investments and certain assets and

                                       56

Table of Contents


accounting for deferred taxes on a different basis. For further discussion
regarding SAP as well as net income (loss) of American Life under SAP, see Note
14 - Statutory Net Income and Surplus to our Consolidated Financial Statements.
As of September 30, 2022, American Life maintained sufficient capital and
surplus to comply with regulatory requirements.

We have reported our insurance subsidiaries' assets, liabilities and results of
operations in accordance with GAAP, which varies from SAP. The following items
are principal differences between SAP and GAAP. SAP:

? requires that we exclude certain assets, called non-admitted assets, from the

balance sheet.

requires us to expense policy acquisition costs when incurred, while GAAP

? allows us to defer and amortize policy acquisition costs over the estimated

life of the policies.

? dictates how much of a deferred income tax asset that we can admit on a

statutory balance sheet.

requires that we record certain investments at cost or amortized cost, while we

? record other investments at fair value; however, GAAP requires that we record

investments that have a readily obtainable valuation at fair value. Investments

without a valuation are carried at amortized cost.

allows bonds to be carried at amortized cost or fair value based on the rating

? received from the Securities Valuation Office of the National Association of

Insurance Commissioners ("NAIC"), while they are recorded at fair value for

GAAP.

allows ceding commission income to be recognized when written if the cost of

? acquiring and renewing the associated business exceeds the ceding commissions,

but under GAAP such income is deferred and recognized over the coverage period.

requires that we record reserves in liabilities and expense for policies

? written, while we record all transactions related to the annuity products under


   GAAP as deposit-type contract liabilities.


   Requires that a provision for reinsurance liability be established for

reinsurance recoverable on paid losses aged over 90 days and for unsecured

? amounts recoverable from unauthorized reinsurers. Under GAAP there is no charge

for uncollateralized amounts ceded to a company not licensed in the insurance

affiliate's domiciliary state and a reserve for uncollectable reinsurance is

charged through earnings rather than surplus or equity.

requires an additional admissibility test outlined in Statements on Statutory

Accounting Principles, No. 101, and the change in deferred income tax is

reported directly in capital and surplus, rather than being reported as a

? component of income tax expense under GAAP. Our insurance subsidiaries must

file with the insurance regulatory authorities an "Annual Statement" which

reports, among other items, net income (loss) and surplus as regards

policyholders, which is called stockholders' equity under GAAP.


State insurance laws and regulations govern the operations of all insurers and
reinsurers such as our insurance and reinsurance company subsidiaries. These
various laws and regulations require that insurance companies maintain minimum
amounts of statutory surplus regarding policyholders and risk-based capital and
determine the dividends that insurers can pay without prior approval from
regulators. The statutory net income of American Life is one of the primary
sources of additions to our statutory surplus, in addition to capital
contributions from us.

                                       57

  Table of Contents

© Edgar Online, source Glimpses